THE UNIVERSITY OF ROCHESTER'S CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE

罗彻斯特大学临床与转化科学研究所

• 批准号: 8173840
• 负责人: THOMAS Arthur PEARSON
• 金额: $ 301.29万
• 依托单位: UNIVERSITY OF ROCHESTER
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-07-01 至 2011-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8173840
• 关键词: Clinical; Institutes; Translational Research; Universities

This subproject represents an estimate of the percentage of the CTSA funding that is being utilized for a broad area of research (AIDS research, pediatric research, or clinical trials). The Total Cost listed is only an estimate of the amount of CTSA infrastructure going towards this area of research, not direct funding provided by the NCRR grant to the subproject or subproject staff. The University of Rochester Clinical and Translational Science Institute (UR CTSI) will be created as the academic home for clinical and translational science, providing a centralized, integrated infrastructure. Under a system of governance in which the UR CTSI Program Director has authority over space, faculty, budgets, and other resources related to the CTSI, and in which much of the current GCRC budget is distributed to CTSI Key Functions in support of these functions, we plan to transform the two distinct research fields of clinical and translational science into a single new discipline. The goals of this discipline nclude the creation of new knowledge and techniques to diagnose, prevent and treat human disease, and he establishment of an environment that catalyzes their application to clinical practice in the community. To achieve these goals, we propose specific aims involving: novel methodologies; pilot studies; upgraded biomedical informatics, epidemiology, research design, ethics, and regulatory support; community engagement; new technology and resource cores; new educational and training programs; an Upstate New York Consortium; and rigorous evaluation and measurement of performance outcomes. Strategic planning for the UR CTSI has been underway for several years prior to this RFA. Evidence of institutional support includes commitment to a new 150,000 sq. ft. Clinical and Translational Science Building (CTSB) in which faculty conducting clinical and translational research will be brought together with students and trainees in existing and new degree-granting programs, with supporting regulatory and administrative functions, and with faculty working in collaborative disciplines such as biostatistics, epidemiology, and biomedical nformatics. The Director and Co-Directors of the UR CTSI will integrate the clinical and translational science functions contained in the CTSB with those functions located at other campus locations, such as functional genomics, other translational resources, and the General Clinical Research Center (GCRC). As an integral part of the CTSI, the GCRC will move into a newly-renovated 10,500 sq ft facility across the street from the CTSB, with enhanced functionality and subject access. As well, the UR CTSI will create two-way synergies with local community groups (school system, faith community, business, foundations) and with other Upstate New York institutions. Further, the UR CTSI will enable the sharing of data across disciplines and across institutions while assuring the privacy and confidentiality of human subjects. In summary, by coalescing and integrating new facilities with enhanced infrastructure, community and state-wide partnerships, a strong foundation of existing research and training, and a fundamentally reorganized administrative structure, the CTSI will transform the conduct of clinical and translational science at UR and contribute nationally to the forging of this new discipline.

该子项目是对CTSA供资的百分比的估计， 用于广泛的研究领域（艾滋病研究，儿科研究，或 临床试验）。 列出的总成本仅为CTSA金额的估算 基础设施走向这一领域的研究，而不是直接提供资金， 向子项目或子项目工作人员提供NCRR补助金。 罗切斯特大学临床和转化科学研究所（UR CTSI）将作为临床和转化科学的学术之家，提供集中的综合基础设施。 在一个管理系统下，UR CTSI项目主任有权管理与CTSI相关的空间、教师、预算和其他资源，并且目前GCRC的大部分预算是 为了支持这些职能，我们计划将临床和转化科学这两个截然不同的研究领域转变为一个新的学科。这门学科的目标包括创造新的知识和技术来诊断，预防和治疗人类疾病，并建立一个环境，促进其在社区临床实践中的应用。为了实现这些目标，我们提出了具体目标，涉及：新方法论;试点研究;升级生物医学信息学、流行病学、研究设计、伦理和监管支持;社区参与;新技术和资源核心;新的教育和培训计划;上州新 约克财团;以及严格评估和衡量业绩成果。在本RFA之前，UR CTSI的战略规划已经进行了几年。机构支持的证据包括承诺新建150，000平方米的住房。英尺临床和转化科学大楼（CTSB）， 从事临床和转化研究的教师将与现有和新的学位授予项目的学生和受训人员聚集在一起，支持监管和行政职能，并与生物统计学、流行病学和生物医学等合作学科的教师一起工作 信息学UR CTSI的主任和联合主任将整合CTSB中包含的临床和转化科学功能与位于其他校园位置的功能，如功能基因组学，其他转化资源和一般临床研究中心（GCRC）。作为整体 作为CTSI的一部分，GCRC将搬进CTSB街对面新装修的10，500平方英尺的设施，功能和主题访问都有所增强。此外，UR CTSI将与当地社区团体（学校系统，信仰社区，企业，基金会）和其他北部地区建立双向协同作用。 纽约的机构。此外，UR CTSI将实现跨学科和跨机构的数据共享，同时确保人类受试者的隐私和机密性。总之，通过合并和整合新设施，加强基础设施，社区和全州范围的伙伴关系， 在现有研究和培训的基础上，以及从根本上重组的行政结构，CTSI将改变临床和转化科学在UR的行为，并在全国范围内为这一新学科的形成做出贡献。